Clik here to view.
武田宣布Ixazomib维持治疗用于新诊断多发性骨髓瘤的全球3期研究入组首例患者
马萨诸塞州剑桥和日本大阪 (美国商业资讯)–武田药品工业株式会社(TSE: 4502)今天宣布，评估研究中的口服新药ixazomib的3期TOURMALINE-MM4研究已入组首例患者。该项优效性研究旨在展示口服给药的蛋白酶体持续抑制能否改善多发性骨髓瘤患者的远期临床转归。...
View ArticleClik here to view.
GORE® EXCLUDER® Iliac Branch Endoprosthesis is First Dedicated System of Its...
FLAGSTAFF, Ariz. W. L. Gore & Associates (Gore) today announced the GORE® EXCLUDER® Iliac Branch Endoprosthesis, the first complete, fully engineered system (Gore designed iliac branch and...
View ArticleClik here to view.
ホライゾン・ディスカバリー・グループとサーモフィッシャーサイエンティフィックが供給・商業化契約を締結
英ケンブリッジ （ビジネスワイヤ） — ゲノム研究と個別化治療薬の開発を促進する研究ツールとサービスを提供する国際的ライフサイエンス企業のホライゾン・ディスカバリー・グループ（LSE:HZD）は本日、科学サービスの世界的リーダー企業サーモフィッシャーサイエンティフィックと供給・商業化契約を締結したと発表しました。...
View ArticleClik here to view.
BeiGene Secures 600 Million RMB ($97 Million US) Financing
GRAND CAYMAN BeiGene Ltd., an innovative oncology company focused on developing targeted and immuno-oncology therapeutics, today announced the successful completion of a $US 97 million financing....
View ArticleClik here to view.
EOS imaging Expands Presence in Asia with First Installation in Hong Kong
PARIS EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced that the Department of Orthopaedics and Traumatology at the Chinese...
View ArticleClik here to view.
Acucela Announces Publication of Pre-clinical Data for Emixustat Hydrochloride
SEATTLE Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of...
View ArticleClik here to view.
Smiths Medical to Sponsor US and Global Symposiums, Exhibitor Theater...
ST. PAUL, Minn. Smiths Medical, a leading global medical device manufacturer, today announced that the Vascular Access business will host three major events in the next two months. They are: an...
View ArticleClik here to view.
Smiths Medical主办美国和全球研讨会，在即将召开的会议上进行展商主会场呈报
明尼苏达州圣保罗 (美国商业资讯)–领先的全球性医疗器械制造商Smiths Medical今天宣布，其血管介入业务部将在接下来2个月主办3场重大的活动。 这些活动包括：5月19日在肯塔基州路易斯维尔召开的输液护理学会(INS)...
View ArticleClik here to view.
Nanova™ Therapy System Now Available from Acelity
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, today announced that Nanova™ Therapy System, a new absorbent dressing enhanced with negative pressure for slow-to-heal...
View ArticleClik here to view.
Arcadia Biosciences, Inc. Announces Pricing of Initial Public Offering
DAVIS, Calif. Arcadia Biosciences, Inc. announced today the pricing of its initial public offering of 8,200,000 shares of its common stock at a public offering price of $8.00 per share. The shares...
View ArticleClik here to view.
Cortendo AB: Cortendo and Antisense Therapeutics Announce Licensing Agreement...
GOTEBORG, Sweden & TREVOSE, Pa. & VICTORIA, Australia Cortendo AB (publ) [ticker: CORT on NOTC-A], a biopharmaceutical company focused on rare endocrine disorders and other rare diseases,...
View ArticleClik here to view.
OMT Therapeutics Announces UniRat™ Alliance with Caltech
PALO ALTO, Calif. OMT Therapeutics, Inc. (OMT Therapeutics) today announced a partnership with the California Institute of Technology (Caltech) under which Caltech will use OMT Therapeutics’ fully...
View ArticleClik here to view.
Arcadia Biosciences, Inc.公布首次公开募股定价
加州戴维斯 (美国商业资讯)– Arcadia Biosciences, Inc.今天公布了其首次公开募股的8,200,000股普通股的公开发行价为8.00美元每股。普通股有望于2015年5月15日在纳斯达克全球市场开始交易，股票代码为“RKDA”。募股活动预计将于2015年5月20日结束，且受到特别成交条件的限制。此外，Arcadia...
View ArticleClik here to view.
MTTI receives expanded patent approval for 99mTc-Duramycin technology to...
WEST CHESTER, Pa. Molecular Targeting Technologies, Inc. (MTTI) announces today that the patent which it has exclusively licensed from the Medical College of Wisconsin (MCW), was granted by the...
View ArticleClik here to view.
Macrogen Enters Exome Sequencing Analysis Service Provision Agreement with...
SEOUL, South Korea The personalized medicine and biotechnology company, Macrogen (CEO Hyonyong Chong, www.macrogen.com) (KOSDAQ:038290) has announced that the company has entered into a genome...
View ArticleClik here to view.
SCIEX and the National University of Singapore Faculty of Science Sign a...
SINGAPORE SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) under the Department of Biological Sciences of the National University of...
View ArticleClik here to view.
S-BIO Launching BlotGlyco® O-Glycan Sample Preparation Kit in U.S., Japan
TOKYO Sumitomo Bakelite Co., Ltd. (TOKYO:4203) will launch “BlotGlyco® O-Glycan Sample Preparation Kit”, a breakthrough new product that enables scientists to analyze O-glycans in biological...
View ArticleClik here to view.
TIELLE® Non Adhesive Foam Dressing Now Available from Acelity
SAN ANTONIO Acelity, a global wound care and regenerative medicine company, today announced that TIELLE® Non Adhesive, a new and improved foam dressing, is now available in Europe. TIELLE® Non...
View ArticleClik here to view.
Hengrui to Collaborate With MabSpace on Novel Antibody Therapeutics
SUZHOU, China MabSpace Biosciences Co., Ltd. announced today that it has signed a collaborative contract with Jiangsu Hengrui Medicine Co., Ltd, one of the leading innovative pharmaceutical...
View ArticleClik here to view.
GI Dynamics Announces Results of First Comparative Study of Gastric Bypass...
LEXINGTON, Mass. & SYDNEY GI Dynamics, Inc. (ASX: GID), a medical device company providing innovative treatments for type 2 diabetes and obesity, today announced data showing improvement in...
View Article